Control Bionics, a global assistive technology company specializing in speech generating devices, is partnering with Complex Rehab Technology (CRT) provider Numotion to expand access to its Trilogy product line.
This partnership will expand access those who can benefit from Control Bionics’ customized Augmentative and Alternative Communication (AAC) solutions designed to help individuals dealing with a wide range of diagnoses, including ALS/MND, spinal muscular atrophy, cerebral palsy, and spinal cord injury, according to a media release from Control Bionics.
“Control Bionics is passionate about helping clients find their ‘voice’ and regain control of their lives. We’re excited to be partnering with Numotion, an established company within the CRT space, to expand access to our life-changing, multi-modal communication solutions throughout the Northeast.”
— Neale Java, CFO at Control Bionics
While Numotion has more than 150 US locations across the US, this partnership will be focused within the states of New Hampshire, Vermont, and New York to increase market awareness of the Control Bionics Trilogy Speech Generating Device as well as its best in class NeuroNode 3.0 sEMG (Electromyography) + Spatial sensor.
“Adding Control Bionics’ Trilogy product line to our offering of AAC devices allows us to better serve those looking for flexible access methods and multi-modal solutions. Their unique approach to AAC devices matches our desire to consistently improve and expand our offerings with cutting edge technology, ultimately offering the greatest benefit to our customers in need.”
— Amanda Whipple, Director of Augmentative Communication at Numotion
Appointments are now available to begin the assessment process for Control Bionics’ products. Both Control Bionics and Numotion offer and support an extensive loan library of devices for clients and their clinicians wishing to trial this latest solution.
[Source(s): Control Bionics, PR Newswire]